{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T16:56:11Z","timestamp":1787676971170,"version":"build-2784847793"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,3,8]],"date-time":"2011-03-08T00:00:00Z","timestamp":1299542400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Inflammation"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1007\/s10753-011-9308-6","type":"journal-article","created":{"date-parts":[[2011,3,8]],"date-time":"2011-03-08T06:28:35Z","timestamp":1299565715000},"page":"221-229","source":"Crossref","is-referenced-by-count":6,"title":["Soluble Urokinase Plasminogen Activator Receptor (suPAR) is Associated with Metabolic Changes in HIV-1-Infected Africans: A Prospective Study"],"prefix":"10.1007","volume":"35","author":[{"given":"Carla M. T.","family":"Fourie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes M.","family":"Van Rooyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annamarie","family":"Kruger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael H.","family":"Olsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesper","family":"Eugen-Olsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rudolph","family":"Schutte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aletta E.","family":"Schutte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,3,8]]},"reference":[{"key":"9308_CR1","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/jmv.21114","volume":"80","author":"O Andersen","year":"2008","unstructured":"Andersen, O., J. Eugen-Olsen, K. Kofoed, J. Iversen, and S.B. Haugaard. 2008. Soluble urokinase plasminogen activator receptor is a marker of dysmetabolism in HIV-infected patients receiving highly active antiretroviral therapy. Journal of Medical Virology 80: 209\u2013216.","journal-title":"Journal of Medical Virology"},{"key":"9308_CR2","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1002\/stem.150398","volume":"15","author":"T Plesner","year":"1997","unstructured":"Plesner, T., N. Behrendt, and M. Ploug. 1997. Structure, function and expression on blood and bone marrow cells of the urokinase-type plasminogen activator receptor, uPAR. Stem Cells 15: 398\u2013408.","journal-title":"Stem Cells"},{"key":"9308_CR3","doi-asserted-by":"crossref","first-page":"4091","DOI":"10.1182\/blood.V96.13.4091","volume":"96","author":"N Sidenius","year":"2000","unstructured":"Sidenius, N., C.F. Sier, H. Ullum, B.K. Pedersen, A.C. Lepri, F. Blasi, and J. Eugen-Olsen. 2000. Serum level of soluble urokinase-type plasminogen activator receptor is a strong and independent predictor of survival in human immunodeficiency virus infection. Blood 96: 4091\u20134095.","journal-title":"Blood"},{"key":"9308_CR4","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/00126334-200404010-00002","volume":"35","author":"SR Ostrowski","year":"2004","unstructured":"Ostrowski, S.R., T.L. Katzenstein, T. Piironen, J. Gerstoft, B.K. Pedersen, and H. Ullum. 2004. Soluble urokinase receptor levels in plasma during 5\u00a0years of highly active antiretroviral therapy in HIV-1-infected patients. Journal of Acquired Immune Deficiency Syndromes 35: 337\u2013342.","journal-title":"Journal of Acquired Immune Deficiency Syndromes"},{"key":"9308_CR5","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/S0140-6736(99)01122-8","volume":"353","author":"B Ledergerber","year":"1999","unstructured":"Ledergerber, B., M. Egger, M. Opravil, A. Telenti, B. Hirschel, M. Battegay, P. Vernazza, P. Sudre, M. Flepp, H. Furrer, P. Francioli, and R. Weber. 1999. Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients: a prospective cohort study. Swiss HIV Cohort Study. Lancet 353: 863\u2013868.","journal-title":"Lancet"},{"key":"9308_CR6","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1126\/science.1070441","volume":"296","author":"B Gaschen","year":"2002","unstructured":"Gaschen, B., J. Taylor, K. Yusim, B. Foley, F. Gao, D. Lang, V. Novitsky, B. Haynes, B.H. Hahn, T. Bhattacharya, and B. Korber. 2002. Diversity considerations in HIV-1 vaccine selection. Science 296: 2354\u20132360.","journal-title":"Science"},{"issue":"2","key":"9308_CR7","first-page":"281","volume":"3","author":"E Freire","year":"2006","unstructured":"Freire, E. 2006. Overcoming HIV-1 resistance to protease inhibitors. Drug Discovery 3(2): 281\u2013286.","journal-title":"Drug Discovery"},{"key":"9308_CR8","doi-asserted-by":"crossref","first-page":"2978","DOI":"10.1001\/jama.289.22.2978","volume":"289","author":"SA Riddler","year":"2003","unstructured":"Riddler, S.A., E. Smit, S.R. Cole, R. Li, J.S. Chmiel, A. Dobs, F. Palella, B. Visscher, R. Evans, and L.A. Kingsley. 2003. Impact of HIV infection and HAART on serum lipids in men. JAMA 289: 2978\u20132982.","journal-title":"JAMA"},{"key":"9308_CR9","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1056\/NEJM199810293391806","volume":"339","author":"A Carr","year":"1998","unstructured":"Carr, A., and D.A. Cooper. 1998. Images in clinical medicine. Lipodystrophy associated with an HIV-protease inhibitor. The New England Journal of Medicine 339: 1296.","journal-title":"The New England Journal of Medicine"},{"key":"9308_CR10","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1056\/NEJMra041811","volume":"352","author":"S Grinspoon","year":"2005","unstructured":"Grinspoon, S., and A. Carr. 2005. Cardiovascular risk and body-fat abnormalities in HIV-infected adults. The New England Journal of Medicine 352: 48\u201362.","journal-title":"The New England Journal of Medicine"},{"key":"9308_CR11","unstructured":"Stankov, M. V., and G. M. Behrens. 2010. Contribution of Inflammation to Fat Redistribution and Metabolic Disturbances in HIV-1 Infected Patients. Curr. Pharm. In press."},{"key":"9308_CR12","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.cca.2005.12.030","volume":"368","author":"J Constans","year":"2006","unstructured":"Constans, J., and C. Conri. 2006. Circulating markers of endothelial function in cardiovascular disease. Clinica Chimica Acta 368: 33\u201347.","journal-title":"Clinica Chimica Acta"},{"key":"9308_CR13","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1161\/01.CIR.0000124480.32233.8A","volume":"109","author":"PY Hsue","year":"2004","unstructured":"Hsue, P.Y., J.C. Lo, A. Franklin, A.F. Bolger, J.N. Martin, S.G. Deeks, and D.D. Waters. 2004. Progression of atherosclerosis as assessed by carotid intima-media thickness in patients with HIV infection. Circulation 109: 1603\u20131608.","journal-title":"Circulation"},{"key":"9308_CR14","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1540-8183.2006.00111.x","volume":"19","author":"JJ Glazier","year":"2006","unstructured":"Glazier, J.J., J.R. Spears, and M.C. Murphy. 2006. Interventional approach to recurrent myocardial infarction in HIV-1 infection. Journal of Interventional Cardiology 19: 93\u201398.","journal-title":"Journal of Interventional Cardiology"},{"key":"9308_CR15","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1056\/NEJMoa062744","volume":"356","author":"N Friis-Moller","year":"2007","unstructured":"Friis-Moller, N., P. Reiss, C.A. Sabin, R. Weber, A. Monforte, W. El-Sadr, R. Thiebaut, S. De Wit, O. Kirk, E. Fontas, M.G. Law, A. Phillips, and J.D. Lundgren. 2007. Class of antiretroviral drugs and the risk of myocardial infarction. The New England Journal of Medicine 356: 1723\u20131735.","journal-title":"The New England Journal of Medicine"},{"key":"9308_CR16","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jinf.2008.01.014","volume":"57","author":"O Andersen","year":"2008","unstructured":"Andersen, O., J. Eugen-Olsen, K. Kofoed, J. Iversen, and S.B. Haugaard. 2008. suPAR associates to glucose metabolic aberration during glucose stimulation in HIV-infected patients on HAART. The Journal of Infection 57: 55\u201363.","journal-title":"The Journal of Infection"},{"key":"9308_CR17","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.thromres.2007.01.011","volume":"120","author":"K Pawlak","year":"2007","unstructured":"Pawlak, K., D. Pawlak, and M. Mysliwiec. 2007. Tissue factor and urokinase-type plasminogen activator system are related to the presence of cardiovascular disease in hemodialysis patients. Thrombosis Research 120: 871\u2013876.","journal-title":"Thrombosis Research"},{"key":"9308_CR18","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.thromres.2007.10.017","volume":"122","author":"K Pawlak","year":"2008","unstructured":"Pawlak, K., M. Mysliwiec, and D. Pawlak. 2008. The urokinase-type plasminogen activator\/its soluble receptor system is independently related to carotid atherosclerosis and associated with CC-chemokines in uraemic patients. Thrombosis Research 122: 328\u2013335.","journal-title":"Thrombosis Research"},{"key":"9308_CR19","unstructured":"UNAIDS. 2008. Sub-Saharan Africa. Aids epidemic update. Regional Summary. Assessed at http:\/\/data.unaids.org\/pub\/Report\/2008\/jc1526_epibriefs_ssafrica_en.pdf on 31 March 2010."},{"key":"9308_CR20","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1080\/17290376.2008.9724904","volume":"5","author":"B Forsyth","year":"2008","unstructured":"Forsyth, B., A. Vandormael, T. Kershaw, and J. Grobbelaar. 2008. The political context of AIDS-related stigma and knowledge in a South African township community. SAHARA Journal 5: 74\u201382.","journal-title":"SAHARA Journal"},{"key":"9308_CR21","doi-asserted-by":"crossref","first-page":"754","DOI":"10.2471\/BLT.08.058982","volume":"87","author":"AJ Herbst","year":"2009","unstructured":"Herbst, A.J., G.S. Cooke, T. Barnighausen, A. KanyKany, F. Tanser, and M.L. Newell. 2009. Adult mortality and antiretroviral treatment roll-out in rural KwaZulu-Natal, South Africa. Bulletin of the World Health Organization 87: 754\u2013762.","journal-title":"Bulletin of the World Health Organization"},{"key":"9308_CR22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ahj.2009.04.019","volume":"158","author":"K Teo","year":"2009","unstructured":"Teo, K., C.K. Chow, M. Vaz, S. Rangarajan, and S. Yusuf. 2009. The Prospective Urban Rural Epidemiology (PURE) study: examining the impact of societal influences on chronic noncommunicable diseases in low-, middle-, and high-income countries. American Heart Journal 158: 1\u20137.","journal-title":"American Heart Journal"},{"key":"9308_CR23","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1007\/s11904-005-0025-3","volume":"2","author":"A Krain","year":"2005","unstructured":"Krain, A., and D.W. Fitzgerald. 2005. HIV antiretroviral therapy in resource-limited settings: experiences from Haiti. Curr HIV\/AIDS Rep 2: 98\u2013104.","journal-title":"Curr HIV\/AIDS Rep"},{"issue":"2","key":"9308_CR24","first-page":"28","volume":"11","author":"A Kruger","year":"2009","unstructured":"Kruger, A., M. Greeff, M. Watson, and C. Fourie. 2009. Health care seeking behaviour of newly diagnosed HIV infected people from rural and urban communities in the North West Province of South Africa. Afr J Nurs 11(2): 28\u201345.","journal-title":"Afr J Nurs"},{"key":"9308_CR25","doi-asserted-by":"crossref","first-page":"12","DOI":"10.4102\/curationis.v30i2.1066","volume":"30","author":"M Greeff","year":"2007","unstructured":"Greeff, M., and R. Phetlhu. 2007. The meaning and effect of HIV\/AIDS stigma for people living with AIDS and nurses involved in their care in the North West Province, South Africa. Curationis 30: 12\u201323.","journal-title":"Curationis"},{"key":"9308_CR26","unstructured":"International Society for the Advancement of Kinanthropometry (ISAK). 2001. International standards for anthropometric assessment. Adelaide: National Library of Australia. P133."},{"key":"9308_CR27","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1093\/clinchem\/43.11.2183","volume":"43","author":"R Johnson","year":"1997","unstructured":"Johnson, R., P. McNutt, S. MacMahon, and R. Robson. 1997. Use of the Friedewald formula to estimate LDL-cholesterol in patients with chronic renal failure on dialysis. Clinical Chemistry 43: 2183\u20132184.","journal-title":"Clinical Chemistry"},{"key":"9308_CR28","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/S1246-7820(01)00131-8","volume":"8","author":"M Peeters","year":"2001","unstructured":"Peeters, M. 2001. The genetic variability of HIV-1 and its implications. Transfusion Clinique et Biologique 8: 222\u2013225.","journal-title":"Transfusion Clinique et Biologique"},{"key":"9308_CR29","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1002\/jmv.20735","volume":"78","author":"GB Jacobs","year":"2006","unstructured":"Jacobs, G.B., C. de Beer, J.E. Fincham, V. Adams, M.A. Dhansay, E.J. van Rensburg, and S. Engelbrecht. 2006. Serotyping and genotyping of HIV-1 infection in residents of Khayelitsha, Cape Town, South Africa. Journal of Medical Virology 78: 1529\u20131536.","journal-title":"Journal of Medical Virology"},{"key":"9308_CR30","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1086\/651117","volume":"50","author":"P Domingo","year":"2010","unstructured":"Domingo, P., M.C. Cabeza, A. Pruvost, J. Salazar, M.M. Gutierrez, M.G. Mateo, J.C. Domingo, I. Fernandez, F. Villarroya, J. Munoz, F. Vidal, and M. Baiget. 2010. Relationship between HIV\/Highly active antiretroviral therapy (HAART)-associated lipodystrophy syndrome and stavudine-triphosphate intracellular levels in patients with stavudine-based antiretroviral regimens. Clinical Infectious Diseases 50: 1033\u20131040.","journal-title":"Clinical Infectious Diseases"},{"key":"9308_CR31","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1097\/00002030-200107270-00008","volume":"15","author":"KA Lichtenstein","year":"2001","unstructured":"Lichtenstein, K.A., D.J. Ward, A.C. Moorman, K.M. Delaney, B. Young, F.J. Palella, P.H. Rhodes, K.C. Wood, and S.D. Holmberg. 2001. Clinical assessment of HIV-associated lipodystrophy in an ambulatory population. AIDS 15: 1389\u20131398.","journal-title":"AIDS"}],"container-title":["Inflammation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-011-9308-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10753-011-9308-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-011-9308-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,17]],"date-time":"2020-06-17T05:39:14Z","timestamp":1592372354000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10753-011-9308-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3,8]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["9308"],"URL":"https:\/\/doi.org\/10.1007\/s10753-011-9308-6","relation":{},"ISSN":["0360-3997","1573-2576"],"issn-type":[{"value":"0360-3997","type":"print"},{"value":"1573-2576","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,3,8]]}}}